These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 4404034)

  • 21. [On the method of action of new types of coronary dilatators with simultaneous oxygen-saving myocardial effects, prenylamine and iproveratril. 2].
    Fleckenstein A; Kammermeier H; Döring HJ; Freund HJ
    Z Kreislaufforsch; 1967 Aug; 56(8):839-58. PubMed ID: 5592708
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta-blockade in experimental myocardial ischaemia: metabolic and electrocardiographic effects.
    Thomas M; Norris R; Opie L; Shulman G; Owen P
    Br Heart J; 1971 Jul; 33(4):609. PubMed ID: 4397629
    [No Abstract]   [Full Text] [Related]  

  • 23. [Adrenergic and anti-adrenergic mechanisms of substances with anti-anginal effects].
    Palm D
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):159-67. PubMed ID: 4389904
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of various coronary vasodilators on myocardial oxygen consumption.
    Oguro K; Kubota K; Kimura T; Hashimoto K
    Jpn J Pharmacol; 1973 Aug; 23(4):459-66. PubMed ID: 4202125
    [No Abstract]   [Full Text] [Related]  

  • 25. [New data on the drug therapy of angina pectoris].
    Urbaszek W
    Z Gesamte Inn Med; 1966 Nov; 21(21):641-9. PubMed ID: 5994727
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effects of various coronary dilators on oxygen consumption, heart frequency and blood pressure in a standardized charge on the ergometer].
    Roskamm H; Fröhlich GJ; Reindell H
    Arzneimittelforschung; 1966 Jul; 16(7):835-41. PubMed ID: 4967662
    [No Abstract]   [Full Text] [Related]  

  • 27. [Coronary dilators].
    Ilic-Vukotić M
    Med Arh; 1972; 26(2):81-4. PubMed ID: 4402269
    [No Abstract]   [Full Text] [Related]  

  • 28. [Inhibition of adenosine uptake and stimulation of its effect on isolated hearts of warm-blooded animals by coronary active substances].
    Pfleger K; Volkmer I; Kolassa N
    Arzneimittelforschung; 1969 Dec; 19(12):1972-4. PubMed ID: 4985338
    [No Abstract]   [Full Text] [Related]  

  • 29. [Phrmacodynamic principles underlying the specific therapy of coronary vascular disease].
    Kraupp O
    Wien Klin Wochenschr; 1973 Feb; 85(8):115-22. PubMed ID: 4144095
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacological approaches to the therapy of angina.
    Parratt JR
    Adv Drug Res; 1974; 9():103-34. PubMed ID: 4156950
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of nitrates and other coronary dilators on large and small coronary vessels: an hypothesis for the mechanism of action of nitrates.
    Winbury MM; Howe BB; Hefner MA
    J Pharmacol Exp Ther; 1969 Jul; 168(1):70-95. PubMed ID: 4978326
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current problems in the medical treatment of coronary insufficiency].
    Cunescu V; Pîrvu V
    Med Interna (Bucur); 1968 Aug; 20(8):899-905. PubMed ID: 4975788
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect upon myocardial blood-flow in man of beta-blocking agents, isosorbide dinitrate, dipyridamole and their combination.
    Reale A; Nigri A; Gioffré PA; Motolese M
    Postgrad Med J; 1970 Nov; ():Suppl:60-6. PubMed ID: 4395461
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical studies on the action of iproveratril in coronary insufficiency and on the influencing of myocardial function using sympatholytics].
    Hofmann H
    Z Gesamte Inn Med; 1968 Jun; 23(12):357-64. PubMed ID: 4386847
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical physiopathological studies on myocardial oxygen metabolism. 3. Myocardial oxygen metabolism during administration of coronary dilators].
    Yokoyama H
    Jpn Circ J; 1971 Jan; 35(1):127-39. PubMed ID: 5108428
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological aspects of the coronary circulation.
    Parratt JR
    Prog Med Chem; 1969; 6():11-66. PubMed ID: 4307053
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on the mechanism of action of INPEA, iproveratril and oxyfedrin].
    Bosse JA; Schaum E
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):221-2. PubMed ID: 4390696
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recent data on coronary dilators].
    Duchêne-Marullaz P; Lavarenne J
    Actual Pharmacol (Paris); 1968; 21():65-116. PubMed ID: 4890107
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hydroxybenzylbenzofuran derivatives of pharmacological and therapeutic interest].
    Deltour G
    Actual Pharmacol (Paris); 1968; 21():117-55. PubMed ID: 4888761
    [No Abstract]   [Full Text] [Related]  

  • 40. Vasodilation in treatment of hypertension.
    Bristow M
    N Engl J Med; 1970 May; 282(19):1102. PubMed ID: 4392413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.